Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102558098A reveals a cost-effective one-pot synthesis for EGFR inhibitor intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN101052604A details a catalytic de-enrichment method for chiral substrates, offering cost-effective recycling of unwanted isomers for pharmaceutical intermediate manufacturing.
Patent CN102558098A details a one-pot synthesis for EGFR inhibitor intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel one-pot method replaces Pd catalysis for EGFR inhibitor intermediates, offering cost-effective scale-up and high purity for pharma supply chains.
Novel patent CN117430650B enables high-purity ivermectin recovery from waste. Reduces hazardous waste and offers cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN85103245A details novel rhodium-diphosphine complexes enabling high-yield asymmetric hydrogenation for pharmaceutical intermediates with reduced catalyst loading.
Patent CN120271438A reveals a Pd-catalyzed method for aryl terminal alkyne. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN120004947A reveals green AlCl3 catalyzed route for phosphorus intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed route enables high-yield aryl terminal alkyne production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1626501A details a high-efficiency ruthenium-catalyzed asymmetric Michael addition for producing optically active nitro and cyano compounds, offering significant cost reduction in API manufacturing.
Patent CN104693194B details organic base catalysis for oxindole derivatives offering cost reduction and high purity for pharmaceutical supply chains.
Patent CN101039894A reveals stabilized Rh-catalyzed asymmetric hydrogenation for high-purity citronellal production, offering significant cost reduction in flavor manufacturing.
Patent CN107698590A details asymmetric cyclization for high-purity nucleosides. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Novel ionic liquid method for 16α-hydroxyprednisolone. Reduces waste and cost. Reliable pharmaceutical intermediates supplier for global supply chains.
Novel Raney Ni catalyzed method for N-[2-(phenylmethyl)phenyl]-2-chloroacetamide. Reduces cost and pollution significantly. Reliable pharmaceutical intermediates supplier.
Novel patent CN101591346B details high-yield synthesis route offering substantial cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN101434609B details a tungstate-catalyzed oxidation of 6-APA. This green process offers high yield and safety for reliable pharmaceutical intermediate supply chains.
Patent CN103833691A reveals a novel acetylation route for producing cis/trans isomeric mixtures of this key fragrance and pharma intermediate with superior yield and purity.
Patent CN104447539B enables efficient aromatic amide production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel mild temperature process for high-purity Valnemulin. Eliminates chromatography, reducing costs for antibiotic manufacturers.